Skip to search formSkip to main contentSkip to account menu

Spiriva

National Institutes of Health

Related topics

Related topics

6 relations
28 ACTUAT tiotropium 0.0025 MG/ACTUAT Metered Dose Inhaler [Spiriva]60 ACTUAT tiotropium 0.0025 MG/ACTUAT Metered Dose Inhaler [Spiriva]tiotropium 0.018 MG Inhalant Powder [Spiriva]

Broader (3)

TIOTROPIUM BROMIDE MONOHYDRATEtiotropiumtiotropium bromide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Effects of Three Dry Powder Inhalers on Deposition of Aerosolized Medicine in the Human Oral-Pharyngeal-Laryngeal Regions
The dry powder inhaler (DPI) is a popular, effective and convenient drug delivery device for inhalation therapy to treat asthma… 
2012
2012
Assessment on the efficacy of seretide combined spiriva in treatment of moderately severe COPD
Objective To observe the therapeutic effect of inhaled seretide combined spiriva in patients with stable moderate and severe… 
Review
2010
Review
2010
Long-acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease
Muscarinic acetylcholine receptor antagonists, particularly of the M3 subtype, are useful therapeutics as bronchodilators in… 
Review
2009
Review
2009
Inhaled muscarinic antagonists for COPD--does an anti-inflammatory mechanism really play a role?
Review
2007
Review
2007
[Tiotropium bromide (Spiriva) in stablechronic obstructive pulmonary disease].
The present review of literature, dedicated to the usage of anticholinergic drug Tiotropium Bromide (Spiriva) in the treatment of… 
2005
2005
[Long-acting m-cholinolytic thiotropium bromide (spiriva) in therapy of patients with chronic obstructive pulmonary disease (stage 3)].
AIM To elicit efficacy of a 3-month treatment with new inhaled cholinolytic drug spiriva in patients with chronic obstructive… 
2005
2005
[Laudatio. On the presentation of the 2005 Robert Koch Award to the drug tiotropium bromide (spiriva)].
  • T. Unger
  • Medizinische Klinik
  • 2005
  • Corpus ID: 36125943
2005
2005
[Pharmacological and clinical profile of tiotropium bromide (Spiriva), a new long-acting anticholinergic bronchodilator for COPD treatment].
2004
2004
Tiotropium (Spiriva): A Once-Daily Inhaled Anticholinergic Medication for Chronic Obstructive Pulmonary Disease
Tiotropium represents a new generation of inhaled therapy. No other inhaled product has demonstrated effectiveness with once… 
Review
2003
Review
2003
[Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)].
Anticholinergics are agents of first choice for the symptomatic treatment of patients with COPD. Tiotropium (Ba 679 BR, Spiriva… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)